Emiliano Calvo Aller on ‘Pharmacology and Dose-Selection of ADCs’ at the ESMO2024 Oral Abstract Session
The START Center for Cancer Care shared on LinkedIn:
“Join START at the ESMO2024 Oral Abstract Session on ‘Current Advances in Clinical Pharmacology Within Oncology, And Its Relevance for Daily Practice,’ co-chaired by our President of Europe and Director of Clinical Research at START Madrid-CIOCC, Emiliano Calvo Aller, on Sunday, September 15, beginning at 16:30.
Dr. Calvo will provide insights on ‘Pharmacology and Dose-Selection of ADCs.’
Other topics in this session include therapeutic drug monitoring of kinase inhibitors, boosting studies to increase drug exposure of anticancer drugs, and the cost-effectiveness of optimized immunotherapy dosing.
We invite you to join us for this invigorating discussion!
Schedule a meeting with our PIs at ESMO to learn more about our innovative work in oncology research.”
